Global Meningococcal Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 104

Published Date: 06 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Meningococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Meningococcal Vaccine size is estimated to be XX million in 2021 from USD 258.3 million in 2020, with a change of XX% between 2020 and 2021. The global Meningococcal Vaccine market size is expected to grow at a CAGR of 4.2% for the next five years.

Market segmentation
Meningococcal Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Meningtits A
    Polysaccharide Meningtitis AC
    Meningitis ACYW

Market segment by Application can be divided into
    6 Months-15Year
    over 3 Year
    over 2 Year
    over 3 Months

The key market players for global Meningococcal Vaccine market are listed below:
    Novartis
    GSK
    Merck
    CSL
    Baxter
    JN International Medical Corporation
    Serum Institute of India
    Bio-Med
    China National Biotec Group
    Hualan Bio
    Walvax
    Zhifei

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Meningococcal Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Meningococcal Vaccine, with price, sales, revenue and global market share of Meningococcal Vaccine from 2019 to 2021.
Chapter 3, the Meningococcal Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Meningococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Meningococcal Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Meningococcal Vaccine Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Meningococcal Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Meningtits A
        1.2.3 Polysaccharide Meningtitis AC
        1.2.4 Meningitis ACYW
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Meningococcal Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 6 Months-15Year
        1.3.3 over 3 Year
        1.3.4 over 2 Year
        1.3.5 over 3 Months
    1.4 Global Meningococcal Vaccine Market Size & Forecast
        1.4.1 Global Meningococcal Vaccine Sales in Value (2016-2026))
        1.4.2 Global Meningococcal Vaccine Sales in Volume (2016-2026)
        1.4.3 Global Meningococcal Vaccine Price by Type (2016-2026) & (USD/Pcs)
    1.5 Global Meningococcal Vaccine Production Capacity Analysis
        1.5.1 Global Meningococcal Vaccine Total Production Capacity (2016-2026)
        1.5.2 Global Meningococcal Vaccine Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Meningococcal Vaccine Market Drivers
        1.6.2 Meningococcal Vaccine Market Restraints
        1.6.3 Meningococcal Vaccine Trends Analysis

2 Manufacturers Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis Meningococcal Vaccine Product and Services
        2.1.4 Novartis Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK Meningococcal Vaccine Product and Services
        2.2.4 GSK Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Merck
        2.3.1 Merck Details
        2.3.2 Merck Major Business
        2.3.3 Merck Meningococcal Vaccine Product and Services
        2.3.4 Merck Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 CSL
        2.4.1 CSL Details
        2.4.2 CSL Major Business
        2.4.3 CSL Meningococcal Vaccine Product and Services
        2.4.4 CSL Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Baxter
        2.5.1 Baxter Details
        2.5.2 Baxter Major Business
        2.5.3 Baxter Meningococcal Vaccine Product and Services
        2.5.4 Baxter Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 JN International Medical Corporation
        2.6.1 JN International Medical Corporation Details
        2.6.2 JN International Medical Corporation Major Business
        2.6.3 JN International Medical Corporation Meningococcal Vaccine Product and Services
        2.6.4 JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Serum Institute of India
        2.7.1 Serum Institute of India Details
        2.7.2 Serum Institute of India Major Business
        2.7.3 Serum Institute of India Meningococcal Vaccine Product and Services
        2.7.4 Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Bio-Med
        2.8.1 Bio-Med Details
        2.8.2 Bio-Med Major Business
        2.8.3 Bio-Med Meningococcal Vaccine Product and Services
        2.8.4 Bio-Med Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 China National Biotec Group
        2.9.1 China National Biotec Group Details
        2.9.2 China National Biotec Group Major Business
        2.9.3 China National Biotec Group Meningococcal Vaccine Product and Services
        2.9.4 China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Hualan Bio
        2.10.1 Hualan Bio Details
        2.10.2 Hualan Bio Major Business
        2.10.3 Hualan Bio Meningococcal Vaccine Product and Services
        2.10.4 Hualan Bio Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 Walvax
        2.11.1 Walvax Details
        2.11.2 Walvax Major Business
        2.11.3 Walvax Meningococcal Vaccine Product and Services
        2.11.4 Walvax Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.12 Zhifei
        2.12.1 Zhifei Details
        2.12.2 Zhifei Major Business
        2.12.3 Zhifei Meningococcal Vaccine Product and Services
        2.12.4 Zhifei Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Meningococcal Vaccine Sales by Manufacturer
    3.1 Global Meningococcal Vaccine Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Meningococcal Vaccine Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Meningococcal Vaccine
    3.4 Market Concentration Rate
        3.4.1 Top 3 Meningococcal Vaccine Manufacturer Market Share
        3.4.2 Top 6 Meningococcal Vaccine Manufacturer Market Share
    3.5 Global Meningococcal Vaccine Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Meningococcal Vaccine Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Meningococcal Vaccine Market Size by Region
        4.1.1 Global Meningococcal Vaccine Sales in Volume by Region (2016-2026)
        4.1.2 Global Meningococcal Vaccine Revenue by Region (2016-2026)
    4.2 North America Meningococcal Vaccine Revenue (2016-2026)
    4.3 Europe Meningococcal Vaccine Revenue (2016-2026)
    4.4 Asia-Pacific Meningococcal Vaccine Revenue (2016-2026)
    4.5 South America Meningococcal Vaccine Revenue (2016-2026)
    4.6 Middle East and Africa Meningococcal Vaccine Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Meningococcal Vaccine Sales in Volume by Type (2016-2026)
    5.2 Global Meningococcal Vaccine Revenue by Type (2016-2026)
    5.3 Global Meningococcal Vaccine Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Meningococcal Vaccine Sales in Volume by Application (2016-2026)
    6.2 Global Meningococcal Vaccine Revenue by Application (2016-2026)
    6.3 Global Meningococcal Vaccine Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Meningococcal Vaccine Sales by Type (2016-2026)
    7.2 North America Meningococcal Vaccine Sales by Application (2016-2026)
    7.3 North America Meningococcal Vaccine Market Size by Country
        7.3.1 North America Meningococcal Vaccine Sales in Volume by Country (2016-2026)
        7.3.2 North America Meningococcal Vaccine Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Meningococcal Vaccine Sales by Type (2016-2026)
    8.2 Europe Meningococcal Vaccine Sales by Application (2016-2026)
    8.3 Europe Meningococcal Vaccine Market Size by Country
        8.3.1 Europe Meningococcal Vaccine Sales in Volume by Country (2016-2026)
        8.3.2 Europe Meningococcal Vaccine Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Meningococcal Vaccine Sales by Type (2016-2026)
    9.2 Asia-Pacific Meningococcal Vaccine Sales by Application (2016-2026)
    9.3 Asia-Pacific Meningococcal Vaccine Market Size by Region
        9.3.1 Asia-Pacific Meningococcal Vaccine Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Meningococcal Vaccine Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Meningococcal Vaccine Sales by Type (2016-2026)
    10.2 South America Meningococcal Vaccine Sales by Application (2016-2026)
    10.3 South America Meningococcal Vaccine Market Size by Country
        10.3.1 South America Meningococcal Vaccine Sales in Volume by Country (2016-2026)
        10.3.2 South America Meningococcal Vaccine Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Meningococcal Vaccine Sales by Type (2016-2026)
    11.2 Middle East & Africa Meningococcal Vaccine Sales by Application (2016-2026)
    11.3 Middle East & Africa Meningococcal Vaccine Market Size by Country
        11.3.1 Middle East & Africa Meningococcal Vaccine Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Meningococcal Vaccine Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Meningococcal Vaccine Typical Distributors
    12.3 Meningococcal Vaccine Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Meningococcal Vaccine Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Meningococcal Vaccine Revenue by Application, (USD Million), 2021-2026
    Table 3. Novartis Basic Information, Manufacturing Base and Competitors
    Table 4. Novartis Major Business
    Table 5. Novartis Meningococcal Vaccine Product and Services
    Table 6. Novartis Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. GSK Basic Information, Manufacturing Base and Competitors
    Table 8. GSK Major Business
    Table 9. GSK Meningococcal Vaccine Product and Services
    Table 10. GSK Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Merck Basic Information, Manufacturing Base and Competitors
    Table 12. Merck Major Business
    Table 13. Merck Meningococcal Vaccine Product and Services
    Table 14. Merck Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. CSL Basic Information, Manufacturing Base and Competitors
    Table 16. CSL Major Business
    Table 17. CSL Meningococcal Vaccine Product and Services
    Table 18. CSL Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. Baxter Basic Information, Manufacturing Base and Competitors
    Table 20. Baxter Major Business
    Table 21. Baxter Meningococcal Vaccine Product and Services
    Table 22. Baxter Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. JN International Medical Corporation Basic Information, Manufacturing Base and Competitors
    Table 24. JN International Medical Corporation Major Business
    Table 25. JN International Medical Corporation Meningococcal Vaccine Product and Services
    Table 26. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Serum Institute of India Basic Information, Manufacturing Base and Competitors
    Table 28. Serum Institute of India Major Business
    Table 29. Serum Institute of India Meningococcal Vaccine Product and Services
    Table 30. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. Bio-Med Basic Information, Manufacturing Base and Competitors
    Table 32. Bio-Med Major Business
    Table 33. Bio-Med Meningococcal Vaccine Product and Services
    Table 34. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. China National Biotec Group Basic Information, Manufacturing Base and Competitors
    Table 36. China National Biotec Group Major Business
    Table 37. China National Biotec Group Meningococcal Vaccine Product and Services
    Table 38. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 40. Hualan Bio Major Business
    Table 41. Hualan Bio Meningococcal Vaccine Product and Services
    Table 42. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. Walvax Basic Information, Manufacturing Base and Competitors
    Table 44. Walvax Major Business
    Table 45. Walvax Meningococcal Vaccine Product and Services
    Table 46. Walvax Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 47. Zhifei Basic Information, Manufacturing Base and Competitors
    Table 48. Zhifei Major Business
    Table 49. Zhifei Meningococcal Vaccine Product and Services
    Table 50. Zhifei Meningococcal Vaccine Sales (10K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 51. Global Meningococcal Vaccine Sales by Manufacturer (2019-2021e) & (10K Pcs)
    Table 52. Global Meningococcal Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 53. Market Position of Manufacturers in Meningococcal Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 54. Global Meningococcal Vaccine Production Capacity by Company, (10K Pcs): 2020 VS 2021
    Table 55. Head Office and Meningococcal Vaccine Production Site of Key Manufacturer
    Table 56. Meningococcal Vaccine New Entrant and Capacity Expansion Plans
    Table 57. Meningococcal Vaccine Mergers & Acquisitions in the Past Five Years
    Table 58. Global Meningococcal Vaccine Sales by Region (2016-2021e) & (10K Pcs)
    Table 59. Global Meningococcal Vaccine Sales by Region (2021-2026) & (10K Pcs)
    Table 60. Global Meningococcal Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 61. Global Meningococcal Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 62. Global Meningococcal Vaccine Sales by Type (2016-2021e) & (10K Pcs)
    Table 63. Global Meningococcal Vaccine Sales by Type (2021-2026) & (10K Pcs)
    Table 64. Global Meningococcal Vaccine Revenue by Type (2016-2021e) & (USD Million)
    Table 65. Global Meningococcal Vaccine Revenue by Type (2021-2026) & (USD Million)
    Table 66. Global Meningococcal Vaccine Price by Type (2016-2021e) & (USD/Pcs)
    Table 67. Global Meningococcal Vaccine Price by Type (2021-2026) & (USD/Pcs)
    Table 68. Global Meningococcal Vaccine Sales by Application (2016-2021e) & (10K Pcs)
    Table 69. Global Meningococcal Vaccine Sales by Application (2021-2026) & (10K Pcs)
    Table 70. Global Meningococcal Vaccine Revenue by Application (2016-2021e) & (USD Million)
    Table 71. Global Meningococcal Vaccine Revenue by Application (2021-2026) & (USD Million)
    Table 72. Global Meningococcal Vaccine Price by Application (2016-2021e) & (USD/Pcs)
    Table 73. Global Meningococcal Vaccine Price by Application (2021-2026) & (USD/Pcs)
    Table 74. North America Meningococcal Vaccine Sales by Country (2016-2021e) & (10K Pcs)
    Table 75. North America Meningococcal Vaccine Sales by Country (2021-2026) & (10K Pcs)
    Table 76. North America Meningococcal Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 77. North America Meningococcal Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 78. North America Meningococcal Vaccine Sales by Type (2016-2021e) & (10K Pcs)
    Table 79. North America Meningococcal Vaccine Sales by Type (2021-2026) & (10K Pcs)
    Table 80. North America Meningococcal Vaccine Sales by Application (2016-2021e) & (10K Pcs)
    Table 81. North America Meningococcal Vaccine Sales by Application (2021-2026) & (10K Pcs)
    Table 82. Europe Meningococcal Vaccine Sales by Country (2016-2021e) & (10K Pcs)
    Table 83. Europe Meningococcal Vaccine Sales by Country (2021-2026) & (10K Pcs)
    Table 84. Europe Meningococcal Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 85. Europe Meningococcal Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 86. Europe Meningococcal Vaccine Sales by Type (2016-2021e) & (10K Pcs)
    Table 87. Europe Meningococcal Vaccine Sales by Type (2021-2026) & (10K Pcs)
    Table 88. Europe Meningococcal Vaccine Sales by Application (2016-2021e) & (10K Pcs)
    Table 89. Europe Meningococcal Vaccine Sales by Application (2021-2026) & (10K Pcs)
    Table 90. Asia-Pacific Meningococcal Vaccine Sales by Region (2016-2021e) & (10K Pcs)
    Table 91. Asia-Pacific Meningococcal Vaccine Sales by Region (2021-2026) & (10K Pcs)
    Table 92. Asia-Pacific Meningococcal Vaccine Revenue by Region (2016-2021e) & (USD Million)
    Table 93. Asia-Pacific Meningococcal Vaccine Revenue by Region (2021-2026) & (USD Million)
    Table 94. Asia-Pacific Meningococcal Vaccine Sales by Type (2016-2021e) & (10K Pcs)
    Table 95. Asia-Pacific Meningococcal Vaccine Sales by Type (2021-2026) & (10K Pcs)
    Table 96. Asia-Pacific Meningococcal Vaccine Sales by Application (2016-2021e) & (10K Pcs)
    Table 97. Asia-Pacific Meningococcal Vaccine Sales by Application (2021-2026) & (10K Pcs)
    Table 98. South America Meningococcal Vaccine Sales by Country (2016-2021e) & (10K Pcs)
    Table 99. South America Meningococcal Vaccine Sales by Country (2021-2026) & (10K Pcs)
    Table 100. South America Meningococcal Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 101. South America Meningococcal Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 102. South America Meningococcal Vaccine Sales by Type (2016-2021e) & (10K Pcs)
    Table 103. South America Meningococcal Vaccine Sales by Type (2021-2026) & (10K Pcs)
    Table 104. South America Meningococcal Vaccine Sales by Application (2016-2021e) & (10K Pcs)
    Table 105. South America Meningococcal Vaccine Sales by Application (2021-2026) & (10K Pcs)
    Table 106. Middle East & Africa Meningococcal Vaccine Sales by Country (2016-2021e) & (10K Pcs)
    Table 107. Middle East & Africa Meningococcal Vaccine Sales by Country (2021-2026) & (10K Pcs)
    Table 108. Middle East & Africa Meningococcal Vaccine Revenue by Country (2016-2021e) & (USD Million)
    Table 109. Middle East & Africa Meningococcal Vaccine Revenue by Country (2021-2026) & (USD Million)
    Table 110. Middle East & Africa Meningococcal Vaccine Sales by Type (2016-2021e) & (10K Pcs)
    Table 111. Middle East & Africa Meningococcal Vaccine Sales by Type (2021-2026) & (10K Pcs)
    Table 112. Middle East & Africa Meningococcal Vaccine Sales by Application (2016-2021e) & (10K Pcs)
    Table 113. Middle East & Africa Meningococcal Vaccine Sales by Application (2021-2026) & (10K Pcs)
    Table 114. Direct Channel Pros & Cons
    Table 115. Indirect Channel Pros & Cons
    Table 116. Meningococcal Vaccine Typical Distributors
    Table 117. Meningococcal Vaccine Typical Customers
List of Figures
    Figure 1. Meningococcal Vaccine Picture
    Figure 2. Global Meningococcal Vaccine Sales Market Share by Type in 2020
    Figure 3. Meningtits A
    Figure 4. Polysaccharide Meningtitis AC
    Figure 5. Meningitis ACYW
    Figure 6. Global Meningococcal Vaccine Sales Market Share by Application in 2020
    Figure 7. 6 Months-15Year
    Figure 8. over 3 Year
    Figure 9. over 2 Year
    Figure 10. over 3 Months
    Figure 11. Global Meningococcal Vaccine Market Size, (USD Million) & (10K Pcs): 2020 VS 2021 VS 2026
    Figure 12. Global Meningococcal Vaccine Market Size and Forecast (2016-2026) & (USD Million)
    Figure 13. Global Meningococcal Vaccine Sales (2016-2026) & (10K Pcs)
    Figure 14. Global Meningococcal Vaccine Price by Type (2016-2026) & (USD/Pcs)
    Figure 15. Global Meningococcal Vaccine Production Capacity (2016-2026) & (10K Pcs)
    Figure 16. Global Meningococcal Vaccine Production Capacity by Geographic Region: 2020 VS 2021
    Figure 17. Meningococcal Vaccine Market Drivers
    Figure 18. Meningococcal Vaccine Market Restraints
    Figure 19. Meningococcal Vaccine Market Trends
    Figure 20. Global Meningococcal Vaccine Sales Market Share by Manufacturer in 2020
    Figure 21. Global Meningococcal Vaccine Revenue Market Share by Manufacturer in 2020
    Figure 22. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 23. Top 3 Meningococcal Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 24. Top 6 Meningococcal Vaccine Manufacturer (Revenue) Market Share in 2020
    Figure 25. Global Meningococcal Vaccine Sales Market Share by Region (2016-2026)
    Figure 26. Global Meningococcal Vaccine Revenue Market Share by Region (2016-2026)
    Figure 27. North America Meningococcal Vaccine Revenue (2016-2026) & (USD Million)
    Figure 28. Europe Meningococcal Vaccine Revenue (2016-2026) & (USD Million)
    Figure 29. Asia-Pacific Meningococcal Vaccine Revenue (2016-2026) & (USD Million)
    Figure 30. South America Meningococcal Vaccine Revenue (2016-2026) & (USD Million)
    Figure 31. Middle East & Africa Meningococcal Vaccine Revenue (2016-2026) & (USD Million)
    Figure 32. Global Meningococcal Vaccine Sales Market Share by Type (2016-2026)
    Figure 33. Global Meningococcal Vaccine Revenue Market Share by Type (2016-2026)
    Figure 34. Global Meningococcal Vaccine Price by Type (2016-2026) & (USD/Pcs)
    Figure 35. Global Meningococcal Vaccine Sales Market Share by Application (2016-2026)
    Figure 36. Global Meningococcal Vaccine Revenue Market Share by Application (2016-2026)
    Figure 37. Global Meningococcal Vaccine Price by Application (2016-2026) & (USD/Pcs)
    Figure 38. North America Meningococcal Vaccine Sales Market Share by Type (2016-2026)
    Figure 39. North America Meningococcal Vaccine Sales Market Share by Application (2016-2026)
    Figure 40. North America Meningococcal Vaccine Sales Market Share by Country (2016-2026)
    Figure 41. North America Meningococcal Vaccine Revenue Market Share by Country (2016-2026)
    Figure 42. United States Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 43. Canada Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 44. Mexico Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Europe Meningococcal Vaccine Sales Market Share by Type (2016-2026)
    Figure 46. Europe Meningococcal Vaccine Sales Market Share by Application (2016-2026)
    Figure 47. Europe Meningococcal Vaccine Sales Market Share by Country (2016-2026)
    Figure 48. Europe Meningococcal Vaccine Revenue Market Share by Country (2016-2026)
    Figure 49. Germany Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. France Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. United Kingdom Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Russia Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Italy Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Asia-Pacific Meningococcal Vaccine Sales Market Share by Region (2016-2026)
    Figure 55. Asia-Pacific Meningococcal Vaccine Sales Market Share by Application (2016-2026)
    Figure 56. Asia-Pacific Meningococcal Vaccine Sales Market Share by Region (2016-2026)
    Figure 57. Asia-Pacific Meningococcal Vaccine Revenue Market Share by Region (2016-2026)
    Figure 58. China Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Japan Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Korea Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. India Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Southeast Asia Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Australia Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. South America Meningococcal Vaccine Sales Market Share by Type (2016-2026)
    Figure 65. South America Meningococcal Vaccine Sales Market Share by Application (2016-2026)
    Figure 66. South America Meningococcal Vaccine Sales Market Share by Country (2016-2026)
    Figure 67. South America Meningococcal Vaccine Revenue Market Share by Country (2016-2026)
    Figure 68. Brazil Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Argentina Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. Middle East & Africa Meningococcal Vaccine Sales Market Share by Type (2016-2026)
    Figure 71. Middle East & Africa Meningococcal Vaccine Sales Market Share by Application (2016-2026)
    Figure 72. Middle East & Africa Meningococcal Vaccine Sales Market Share by Country (2016-2026)
    Figure 73. Middle East & Africa Meningococcal Vaccine Revenue Market Share by Country (2016-2026)
    Figure 74. Turkey Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Egypt Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Saudi Arabia Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. South Africa Meningococcal Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Sales Channel: Direct Channel vs Indirect Channel
    Figure 79. Methodology
    Figure 80. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei

Related Reports

Global Meningococcal Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Meningococcal Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

The Meningococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Meningococcal Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Meningococcal Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.

Global Meningococcal Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Meningococcal Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Meningococcal Vaccine market size was valued at USD 269.6 million in 2023 and is forecast to a readjusted size of USD 359.8 million by 2030 with a CAGR of 4.2% during review period.

Global Meningococcal Vaccine Supply, Demand and Key Producers, 2024-2030

Global Meningococcal Vaccine Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Pharma & Healthcare

The global Meningococcal Vaccine market size is expected to reach $ 359.8 million by 2030, rising at a market growth of 4.2% CAGR during the forecast period (2024-2030).

Product Tags

meningococcal vaccine

Quadrivalent Meningococcal Vaccine

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>